(Q34367110)

1 August 2017

1 reference

title

Growth hormone treatment: cancer risk (English)

1 reference

1 August 2017

Charles A Sklar

1

1 reference

1 August 2017

1 January 2004

1 reference

1 August 2017

1 reference

1 August 2017

62 Suppl 3

1 reference

1 August 2017

30-34

1 reference

Insulin-like growth factors and cancer

1 August 2017

1 reference

The insulin-like growth factor system and cancer

21 January 2018

1 reference

The IGF‐1 receptor in cancer biology

21 January 2018

1 reference

Does the GH-IGF axis play a role in cancer pathogenesis?

21 January 2018

1 reference

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

21 January 2018

1 reference

Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study

21 January 2018

1 reference

Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

21 January 2018

1 reference

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.

21 January 2018

1 reference

Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.

21 January 2018

1 reference

Second cancers in survivors of childhood cancer

21 January 2018

1 reference

Growth hormone and neurofibromatosis

21 January 2018

1 reference

Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000080496

1 reference

release_yi76spz6fvct7cigwfu34qjii4

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yi76spz6fvct7cigwfu34qjii4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15539796

1 reference

PubMed ID

15539796